CNS cancer clinical trials require specialized drug delivery. Cerenome CEO Dr. Marc Hedrick discusses site selection, neurosurgical needs and future access.
News
Life Science News
Pharma News
Biotech News
Medical Device News
Healthcare News
Videos
Blogs
Life Sciences Quizzes & Polls